Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization277 mentions
- NVIDIAorganization265 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
pancreatic cancer treatment
market8 mentionslast seen Nov 9, 2026
Pancreatic cancer indication.
Relationships 5
- pelareorepapplies topancreatic cancer treatment99% confidence4 sources
- MT-601applies topancreatic cancer treatment95% confidence1 source
- single-cell analysisapplies topancreatic cancer treatment82% confidence1 source
- small molecule drug discoveryapplies topancreatic cancer treatment78% confidence1 source
- antibody-drug conjugateapplies topancreatic cancer treatment76% confidence1 source
Relationship
pelareorepapplies topancreatic cancer treatment
99% confidence4 supporting mentions
Either name opens that entity’s relationships.
Sources 4
- filingSEC EDGARNov 9, 2026ONCOLYTICS BIOTECH INC 8-K: Item 8.01: Other Events
multiple first-line pancreatic cancer studies
- filingSEC EDGAROct 20, 2026ONCOLYTICS BIOTECH INC 8-K: Item 8.01: Other Events
demonstrated encouraging results in multiple first-line pancreatic cancer studies
- filingSEC EDGAROct 14, 2026ONCOLYTICS BIOTECH INC 8-K: Item 8.01: Other Events
first-line metastatic pancreatic ductal adenocarcinoma ("PDAC")
- filingSEC EDGARSep 29, 2026ONCOLYTICS BIOTECH INC 8-K: Item 8.01: Other Events
Pelareorep has demonstrated encouraging results in multiple first-line pancreatic cancer studies